Ind-Swift Laboratories' Q2 FY 2025-26 Quarterly Results

Result Summary

• Ind-Swift Laboratories Ltd reported a 1.9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 583.1%.
• Its expenses for the quarter were up by 2.0% QoQ and 556.9% YoY.
• The net profit decreased 8.9% QoQ and increased 1848.8% YoY.
• The earnings per share (EPS) of Ind-Swift Laboratories Ltd stood at 0.96 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Ind-Swift Laboratories Ltd is a prominent player in the pharmaceutical industry, known for its focus on developing and manufacturing a wide range of pharmaceutical products. The company specializes in the production of Active Pharmaceutical Ingredients (APIs) and intermediates, catering to both domestic and international markets. Over the years, Ind-Swift Laboratories has established itself as a reliable supplier in the pharmaceutical supply chain. While specific recent developments are not detailed within the data provided, the company typically engages in activities such as expanding its product portfolio and enhancing its manufacturing capabilities to maintain its competitive edge.

Revenue

In the second quarter of the fiscal year 2026 (Q2FY26), Ind-Swift Laboratories Ltd reported a total income of ₹170.50 crores. This marks an increase of 1.9% from the previous quarter (Q1FY26), where the total income was ₹167.32 crores. Year-over-year, the company experienced a significant growth of 583.1%, as the total income for the second quarter of the fiscal year 2025 (Q2FY25) was ₹24.96 crores. This substantial year-over-year growth indicates a major increase in revenue generation over the past year.

Profitability

The company's profit before tax for Q2FY26 was ₹10.34 crores, slightly decreasing by 0.1% from ₹10.35 crores in Q1FY26. However, when compared to Q2FY25, this figure represents a significant year-over-year increase of 1682.8%, as the profit before tax during that period was ₹0.58 crores. The profit after tax for Q2FY26 was ₹7.99 crores, showing a decline of 8.9% from ₹8.77 crores in Q1FY26. Despite this quarter-over-quarter decline, the year-over-year comparison reveals an impressive growth of 1848.8%, from ₹0.41 crores in Q2FY25. The earnings per share (EPS) in Q2FY26 stood at ₹0.96, reflecting a decrease of 17.9% from ₹1.17 in the previous quarter and a notable increase of 1271.4% year-over-year from ₹0.07 in Q2FY25.

Operating Metrics

The total expenses for Q2FY26 were recorded at ₹160.16 crores, which represents a growth of 2.0% from ₹156.96 crores in Q1FY26. Year-over-year, there was a substantial increase of 556.9% from ₹24.38 crores in Q2FY25. The tax expenses for Q2FY26 amounted to ₹2.30 crores, marking a significant increase of 34.5% from ₹1.71 crores in Q1FY26 and an even more substantial rise of 1177.8% compared to ₹0.18 crores in Q2FY25. These financial metrics highlight the scale of operational growth and the associated costs over the observed periods.